
Protein Kinase C 19-31
CAS No. 121545-65-1
Protein Kinase C 19-31( PKC (19-31) )
Catalog No. M29752 CAS No. 121545-65-1
Protein Kinase C (19-31), a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is used as protein kinase C substrate peptide for testing the protein kinase C activity.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameProtein Kinase C 19-31
-
NoteResearch use only, not for human use.
-
Brief DescriptionProtein Kinase C (19-31), a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is used as protein kinase C substrate peptide for testing the protein kinase C activity.
-
DescriptionProtein Kinase C (19-31), a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is used as protein kinase C substrate peptide for testing the protein kinase C activity.
-
In Vitro——
-
In Vivo——
-
SynonymsPKC (19-31)
-
PathwayTGF-beta/Smad
-
TargetTGFBR
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number121545-65-1
-
Formula Weight1543.82
-
Molecular FormulaC67H118N26O16
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : ≥ 50 mg/mL (32.39 mM)
-
SMILES——
-
Chemical NameSequence:{Arg}{Phe}{Ala}{Arg}{Lys}{Gly}{Ala}{Leu}{Arg}{Gln}{Lys}{Asn}{Val}
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Mellor H, et al. The extended protein kinase C superfamily. Biochem J. 1998 Jun 1;332 ( Pt 2):281-92.
molnova catalog



related products
-
LY2109761
A potent, selective and orally active TGF-β RI/II dual inhibitor with Ki of 38/300 nM, respectively.
-
FT-011
A novel anti-fibrotic agent that prevents TGF-beta-stimulated production of collagen in cultured renal mesangial cells (55-70% inhibition at 30 uM).
-
AZ12601011
AZ12601011 (AZ-12601011) is a potent, selective inhibitor of ALK4, ALK7 and TGFBR1 (Kd=2.9 nM).